Skip to main content
Premium Trial:

Request an Annual Quote

Wageningen University & Research Centre, KeyGene Open NGS Facility with HiSeq 2000, PacBio RS

Premium

Wageningen University & Research Centre and agricultural biotech firm KeyGene will open a joint next-generation DNA sequencing facility for their researchers, customers, and collaborators, the two Dutch organizations said this week.

The new facility, which will be equipped with an Illumina HiSeq 2000, a PacBio RS sequencer, and bioinformatics infrastructure, is funded with €1.7 million ($2.3 million), which includes support from CAT-AgroFood, a joint organization of the Dutch government, the province of Gelderland, and Wageningen UR.

Researchers will use the facility to study microbial, plant, animal, and human samples in projects that will be executed by either KeyGene or Wageningen UR. KeyGene plans to use the new resource for sequence-based plant-breeding applications that the company has developed over the last few years, such as a physical mapping method (IS 2/1/2011), a mutation detection method, a SNP identification method, and a genotyping method.

In addition, the facility is expected to enhance collaborations between Wageningen UR and KeyGene.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.